Protelos® (strontium ranelate) is the first anti-osteoporotic treatment to demonstrate an early and sustained reduction for vertebral and non-vertebral fractures in women over 80 years of age. Results announced last night at the Sixth European Congress on Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ECCEO), from trials of 1,488 women, show that even in the very elderly, it is not too late to effectively treat the disease.